The opioid business plan
Insys Therapeutics was an opioid startup that made lots of money for its addictive nasal spray. Today, we hear from Evan Hughes, author of the book Hard Sell: Crime and Punishment at an Opioid Startup, on how the company's carelessness led to its ultimate downfall.